Raymond James Maintains Liquidia (LQDA) Buy Rating and Raises Price Target to $77
Raymond James analyst Ryan Deschner has maintained a 'Buy' rating on Liquidia Corporation while increasing the price target from $53 to $77.
Stocks · News reference
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
Liquidia Corporation announced that its CEO and CFO/COO will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on November 17, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BTIG Analyst Raises Liquidia Price Target to $87
BTIG analyst Julian Harrison has maintained a 'Buy' rating on Liquidia Corporation and increased the price target from $70 to $87.
Needham Maintains Buy Rating and Raises Price Target for Liquidia
Needham has reaffirmed its 'Buy' rating on Liquidia Corporation and increased its price target for the company's stock to $66.
Liquidia Q3 2026 Earnings Call Transcript
Liquidia (NASDAQ:LQDA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time access to earnings call
UPDATE: Liquidia Q3 Adj. EPS $1.71 Beats $0.96 Estimate, Sales $225.000M Beat $214.182M Estimate (Adj EPS Excludes Litigation Settlement)
Liquidia Corporation Reports Third Quarter 2026 Financial Results
Liquidia Corporation reported its financial results for the third quarter ended September 30, 2026, and scheduled a conference call to discuss the outcomes.